ACON vs BOLT
Comparison between Aclarion Inc (ACON, Company) and Bolt Biotherapeutics Inc (BOLT, Company).
Both ACON and BOLT are from the Healthcare sector.
ACON vs BOLT - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
Market Cap
ACON
$7.63M
Winner
BOLT
$7.67M
Max Drawdown
ACON
100.00%
Winner
BOLT
99.51%
Sharpe Ratio
ACON
-0.49
Winner
BOLT
-0.18
5Y Beta
Winner
ACON
0.00
BOLT
0.92
Industry
ACON
Health Information Services
BOLT
Biotechnology
P/E Ratio
Winner
ACON
-0.34
BOLT
-0.26
5Y EPS CAGR
ACON
N/A
BOLT
-16.86%
Debt to Equity
ACON
0.00%
BOLT
0.00%
Free Cash Flow Yield
ACON
-95.92%
BOLT
N/A
ACON vs BOLT - Historical Returns
Returns include dividend reinvestment.
1M
Winner
ACON
-2.50%
BOLT
-8.49%
3M
Winner
ACON
-6.02%
BOLT
-13.92%
6M
ACON
-50.79%
Winner
BOLT
-22.60%
1Y
ACON
-57.44%
Winner
BOLT
-29.51%
5Y(CAGR)
ACON
-94.08%
Winner
BOLT
-58.34%
Max(CAGR)
ACON
-94.08%
Winner
BOLT
-61.23%
ACON vs BOLT - Annual Returns (2021 - 2026)
Returns include dividend reinvestment.
| Year | ACON | BOLT |
|---|---|---|
| 2026 | -37.35% | -31.09% |
| 2025 | -99.64% | -52.04% |
| 2024 | -95.66% | -53.87% |
| 2023 | -64.91% | -18.25% |
| 2022 | -78.68% | -73.03% |
| 2021 | N/A | -84.76% |
ACON vs BOLT Drawdown Comparison
The maximum drawdown for ACON was -100.00%, occurring on Feb 5, 2026. This drawdown has not yet recovered.
The maximum drawdown for BOLT was -99.51%, occurring on Mar 13, 2026. This drawdown has not yet recovered.
The current ACON drawdown is -100.00%. The current BOLT drawdown is -99.50%.
| Rank | ACON | BOLT |
|---|---|---|
| #1 | -100.00% Apr 22, 2022 - Feb 5, 2026 | -99.51% Mar 17, 2021 - Mar 13, 2026 |
| #2 | N/A | -22.70% Feb 10, 2021 - Mar 9, 2021 |
| #3 | N/A | -0.51% Mar 12, 2021 - Mar 16, 2021 |
| #4 | N/A | -0.20% Mar 9, 2021 - Mar 11, 2021 |
Correlation
Correlation between ACON and BOLT is 0.81 which considered as a strong positive correlation - the stocks tend to move together.
0.81
-101
Select Stocks to Compare
Popular: ACON vs SPYBOLT vs SPY
More Comparisons
Compare with similar stocks